Congress Should Support Access to Post-Conviction DNA Testing
By Kirk Bloodsworth,
The Hill
| 07. 29. 2015
I'll never forget how lonely I felt when the jury announced its guilty verdict and the courtroom erupted in applause. I thought, how could this happen? It felt surreal, but soon after reality sunk in: I could spend the rest of my life in prison until the state of Maryland executed me. I spent eight years, 11 months and 19 days locked away — two of those years on death row — for a rape and murder that I did not commit, before post-conviction DNA testing proved my innocence.
If not for post-conviction DNA testing, I might still be in prison, or worse, I could have been executed. In 1993, I became the first death-row inmate in the U.S. to be exonerated by DNA testing. Since then, I have dedicated my life to advocating for reforms that will both prevent and identify wrongful convictions.
Recently I had the opportunity to make a case for criminal justice reform as a participant in the Coalition for Public Safety’s and Cut50’s Bipartisan Fair Justice Summit. This year, Congress can support reform by passing...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...